Grifols, S.a. share price logo

Grifols, S.a. Share Price

NASDAQ: GRFS

Mid Cap

$7.60

-0.09

(-1.17%)

as on

Grifols, S.a. Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $7.57
    $7.71
    downward going graph

    0.39%

    Downside

    1.45%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.19
    $11.14
    downward going graph

    18.55%

    Downside

    46.58%

    Upside

    downward going graph

Grifols, S.a. share price movements today

Previous Close
$7.69
Open
$7.59
Volume
1.2M
Day's Low - High
$7.57 - $7.71
52 Week Low - High
$6.19 - $11.14

Grifols, S.a. Historical Returns

1 Month Return
-16.86 %
3 Month Return
-14.84 %
1 Year Return
+ 1.85 %
3 Year Return
+ 12.26 %
5 Year Return
-55.91 %

Grifols, S.a. Stock Fundamentals & Key Indicators

Check Grifols, S.a. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.6B

EPS (TTM)

0.8717

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

7.50%

PE Ratio (TTM)

13.81

Industry PE ratio

7.867522123893806

PEG Ratio

0.229

EBITDA

1.8B

Revenue (TTM)

7.5B

Profit Margin

4.96%

Return On Equity TTM

5.89%

Grifols, S.a. Stock Valuation

Track how Grifols, S.a. P/E has moved over time to understand its valuation trends.

Grifols, S.a. in the last 5 years

  • Overview

  • Trends

Lowest (11.20x)

December 31, 2025

Industry (7.87x)

March 25, 2026

Today (13.81x)

March 25, 2026

Highest (37.12x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: 13.81x

Grifols, S.a. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Grifols, S.a. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Grifols, S.a. image
Grifols, S.a.
BUY$7.6B-55.91%13.814.96%
ASTRAZENECA PLC image
ASTRAZENECA PLC
BUY$284.6B270.36%28.0717.41%
Eli Lilly And Company image
Eli Lilly And Company
BUY$811.5B397.32%39.5231.67%
Johnson & Johnson image
Johnson & Johnson
BUY$567.2B45.35%21.3228.46%
Abbvie Inc image
Abbvie Inc
BUY$362.6B97.28%86.166.91%
See all

Stock Returns calculator for Grifols, S.a. Stock including INR - Dollar returns

The Grifols, S.a. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Grifols, S.a. investment value today

Current value as on today

₹1,10,203

Returns

₹10,203

(+10.2%)

Returns from Grifols, S.a. Stock

₹662 (+0.66%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Grifols, S.a. Stock

Based on 22 analysts

BUY

63.64%

Buy

22.73%

Hold

13.64%

Sell

Based on 22 analysts, 63.64% of analysts recommend a 'BUY' rating for Grifols, S.a.. Average target price of $12.53

Grifols, S.a. Share Price Target

Get share price movements and forecasts by analysts on Grifols, S.a..

What analysts predicted

39.35%UPSIDE

Target Price

$12.53

Current Price

$7.6

Analyzed by

22 Analysts

Target

$12.53

Grifols, S.a. target price $12.53, a slight upside of 39.35% compared to current price of $7.6. According to 22 analysts rating.

Grifols, S.a. Stock’s Investor Sentiment and Interest

Search interest for Grifols, S.a. Stock has increased by 9% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:9% versus previous 30 day period

Grifols, S.a. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
1,705
1,930
1,625
1,956
1,990
2,067
1,785
1,891
1,865
1,963
Gross Profit
674
752
648
721
806
801
704
743
751
680
Operating Income
250
223
203
299
317
371
268
348
383
272
EBITDA
358
334
347
297
425
336
404
347
457
395
Interest Expense
150
91
169
202
197
15
153
141
156
158
Depreciation
108
105
-
27
108
110
-
15
-
-
Income Before Tax
99
76
47
66
119
210
115
190
198
110
Income Tax Expense
5
27
24
42
37
126
22
52
54
-14
Net Income
63
61
21
15
57
72
59
117
126
97
Net Profit Margin
3.73%
3.16%
1.32%
0.82%
2.88%
3.49%
3.34%
6.19%
6.81%
4.96%

Grifols, S.a. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
4,049
4,318
4,486
5,098
5,340
5,576
6,417
7,191
7,545
7,227
Gross Profit
1,912
2,152
2,049
2,341
2,255
2,218
2,342
2,709
2,923
2,579
Operating Income
939
1,003
994
1,131
996
595
782
782
1,192
1,187
EBITDA
1,147
1,190
1,258
1,443
1,423
944
1,193
1,169
1,484
1,619
Interest Expense
228
249
274
324
284
233
444
516
773
600
Depreciation
-
215
228
302
321
359
407
441
437
-
Income Before Tax
712
695
725
817
878
350
338
207
443
590
Income Tax Expense
168
34
131
168
169
85
90
43
231
110
Net Income
545
662
596
625
618
213
195
46
164
386
Net Profit Margin
13.47%
15.35%
13.30%
12.26%
11.58%
3.83%
3.05%
0.64%
2.18%
5.34%

Grifols, S.a. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
55
21
14
51
68
59
117
126
97
Operating Cash Flow
156
-164
252
299
514
135
155
325
418
Investing Cash Flow
-141
-87
1,349
-196
-178
-197
-107
-122
-148
Financing Cash Flow
46
165
59
-1,556
-27
-133
-181
-138
-74
Change in Cash
32
-81
1,664
-1,468
334
-226
-194
62
203

Grifols, S.a. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
695
725
817
878
350
361
207
443
386
Operating Cash Flow
841
737
568
1,110
596
-10
218
902
1,005
Investing Cash Flow
-2,185
-781
-548
-858
-29
-1,978
-394
886
-556
Financing Cash Flow
1,434
152
-332
-354
1,472
-173
171
-1,358
-508
Change in Cash
-8
147
-291
-162
2,095
-2,127
-19
450
-38

Global Institutional Holdings in Grifols, S.a.

Funds
Holdings
Brandes Investment Partners & Co
4.28%
Black Creek Investment Management Inc
1.36%
Harris Associates L.P.
0.4%
SEI Investments Co
0.21%
New York State Common Retirement Fund
0.36%
See all

Grifols, S.a. News & Key Events

  • img

    Today's Timeline - 24 March

    Wed, 02:38 AM

    -

    Grifols approves IPO for its U.S. biopharma business to raise capital and support strategic priorities.

Insights on Grifols, S.a.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.86B → 1.96B (in $), with an average increase of 5.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, ASTRAZENECA PLC has given 171.0% return, outperforming this stock by 158.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, ASTRAZENECA PLC has given 152.0% return, outperforming this stock by 150.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 126.96M → 97.32M (in $), with an average decrease of 23.3% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, GRFS stock has moved down by -16.9%

About Grifols, S.a.

for more than 75 years, grifols has been improving the health and well-being of people. our patients are our priority, and our commitment to their health has enabled us to become a global healthcare leader with presence in more than 100 countries. the grifols legacy embodies a spirit of innovation and a forward thinking approach and establish us as an international benchmark in the plasma collection market, the production of plasma derived therapies and transfusion medicine. grifols has three business divisions: bioscience brings together all plasma related activities including research, development, collection, production and sales of life-saving plasma derived therapies. diagnostic provides innovative solutions to support safe and compatible transfusions, monitor therapies, and detect infectious and autoimmune diseases. research novel technologies to further improve treatment outcomes and laboratory efficiency. hospital specializes in non-biological pharmaceutical products. t
OrganisationGrifols, S.a.
HeadquartersParque Empresarial Can Sant Joan, Barcelona, Spain, 08174
IndustryHealth Technology
CEOMr. Jose Ignacio Abia Buenache
E-voting on sharesClick here to vote

Key Management of Grifols, S.a.

Name

Title

Mr. Enrique de la Torre

Chief Compliance Officer

Ms. Montse Ribas

Chief Communications and Reputation Officer

Mr. Camille Alpi

Chief Human Resources & Talent Officer

Mr. Rahul Srinivasan

Chief Financial Officer

Mr. Lluis Pons Gomez

Senior Vice President of Strategy & COO Office

Daniel Segarra

Head of Investor Relations & Sustainability and Vice President

Mr. David Ian Bell

Chief Corporate Affairs & Legal Officer

Mr. Jose Ignacio Abia Buenache

CEO & Director

Mr. Vicente Blanquer Torre

Chief Quality Officer

Mr. Sergio Roura Adell

President of Commercial Tech Support

FAQs

What is Grifols, S.a. share price today?

Grifols, S.a. share price today is $7.6 as on at the close of the market. Grifols, S.a. share today touched a day high of $7.71 and a low of $7.57.

What is the 52 week high and 52 week low for Grifols, S.a. share?

Grifols, S.a. share touched a 52 week high of $11.14 on and a 52 week low of $6.19 on . Grifols, S.a. stock price today i.e. is closed at $7.6,which is 31.78% down from its 52 week high and 22.78% up from its 52 week low.

What is Grifols, S.a.'s market capitalisation today?

Grifols, S.a. market capitalisation is $0.01T as on .

How to invest in Grifols, S.a. Stock (GRFS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Grifols, S.a. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Grifols, S.a. Shares that will get you 0.1974 shares as per Grifols, S.a. share price of $7.6 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Grifols, S.a. Stock (GRFS) from India?

Indian investors can start investing in Grifols, S.a. (GRFS) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Grifols, S.a. stock (as per the Rupee-Dollar exchange rate as on ). Based on Grifols, S.a. share’s latest price of $7.6 as on March 25, 2026 at 1:29 am IST, you will get 1.3158 shares of Grifols, S.a.. Learn more about fractional shares .

What are the returns that Grifols, S.a. has given to Indian investors in the last 5 years?

Grifols, S.a. stock has given -55.91% share price returns and 28.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?